Supha Pharmachem Limited
Promoter holding in Supha Pharmachem Limited was 1.13% in Dec 2025.
By quarter
Quarter by quarter
| Quarter | Promoters | Public |
|---|---|---|
| Dec '25 | 1.13% | 98.87% |
Compared with similar companies
Promoter holding in Supha Pharmachem Limited is lower than 99% of companies in the Healthcare sector in India.
| Company | Promoters |
|---|---|
| Supha Pharmachem Limited | 1.13% |
| Ortin Global Limited | 1.23% |
| Biofil Chemicals and Pharmaceuticals Limited | 46.79% |
| Balaxi Pharmaceuticals Limited | 65.99% |
| Krebs Biochemicals & Industries Limited | 72.74% |
| Par Drugs and Chemicals Limited | 73.41% |
Similar-sized companies in the same sector, latest quarter on record.
Questions
What is Supha Pharmachem Limited's promoter holding?
Promoters held 1.13% of Supha Pharmachem Limited as of 31 Dec 2025, and the public held 98.87%.
Are any promoter shares of Supha Pharmachem Limited pledged?
No promoter shares are recorded as pledged.
How does Supha Pharmachem Limited's promoter holding compare with similar companies?
Promoter holding in Supha Pharmachem Limited is lower than 99% of companies in the Healthcare sector in India. A higher or lower promoter holding is not good or bad by itself.
From the company's quarterly shareholding filings. "Public" includes institutions (foreign and domestic) and individual investors; a split by investor type is planned. ▲/▼ shows the change from the previous quarter, in percentage points. PositoAI is for research and education only and is not investment advice.